These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8209101)

  • 41. How important is phosphate in the pathogenesis of renal osteodystrophy?
    Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
    Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
    [No Abstract]   [Full Text] [Related]  

  • 42. Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.
    Rutherford WE; Bordier P; Marie P; Hruska K; Harter H; Greenwalt A; Blondin J; Haddad J; Bricker N; Slatopolsky E
    J Clin Invest; 1977 Aug; 60(2):332-41. PubMed ID: 874095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parathyroidectomy and renal insufficiency.
    Wilson RE
    Surg Annu; 1973; 5():121-43. PubMed ID: 4602212
    [No Abstract]   [Full Text] [Related]  

  • 44. Calcium and phosphorus metabolism in uremia and renal transplantation: an experimental model.
    Mitchell TS; Lee S; Gittes RF
    Invest Urol; 1974 Nov; 12(3):186-92. PubMed ID: 4613687
    [No Abstract]   [Full Text] [Related]  

  • 45. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
    Portale AA; Morris RC
    Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.
    de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J
    Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal osteodystrophy in rats with reduced renal mass.
    Moscovici A; Bernheim J; Popovtzer MM; Rubinger D
    Nephrol Dial Transplant; 1996; 11 Suppl 3():146-52. PubMed ID: 8840331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent hyperparathyroidism in renal transplant patients.
    Pabico RC; Ward HN; McKenna BA; Freeman RB
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():68-72. PubMed ID: 226952
    [No Abstract]   [Full Text] [Related]  

  • 50. Current issues in the management of secondary hyperparathyroidism and bone disease.
    Moe SM
    Perit Dial Int; 2001; 21 Suppl 3():S241-6. PubMed ID: 11887830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone disease in pediatric chronic kidney disease.
    Wesseling-Perry K
    Pediatr Nephrol; 2013 Apr; 28(4):569-76. PubMed ID: 23064662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fractures and chronic renal insufficiency].
    Isaia GC; Tamone C; Ravazzoli M
    G Ital Nefrol; 2008; 25(1):57-65. PubMed ID: 18264919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long term results of subtotal parathyroidectomy in patients with end-stage renal disease.
    Kim HC; Cheigh JS; David DS; Stubenbord W; Sullivan J; Rubin AL; Stenzel KH
    Am Surg; 1994 Sep; 60(9):641-9. PubMed ID: 8060033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal secondary hyperparathyroidism in dogs.
    Stillion JR; Ritt MG
    Compend Contin Educ Vet; 2009 Jun; 31(6):E8. PubMed ID: 19746344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency].
    Pérez-García R; Jofre R; Vasconez F; Caballero A; Valderrábano F
    Rev Clin Esp; 1982 Feb; 164(3):159-52. PubMed ID: 7089332
    [No Abstract]   [Full Text] [Related]  

  • 56. Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ
    Kidney Int; 2007 Sep; 72(5):582-91. PubMed ID: 17554252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of parathyroid pituitary-specific transcription factor (Pit)-1 in hyperphosphatemia-induced hyperparathyroidism of chronic renal failure rats.
    Jiang Y; Wang M
    Chin Med J (Engl); 2010 Jun; 123(12):1566-70. PubMed ID: 20819513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism.
    Llach F; Massry SG; Singer FR; Kurokawa K; Kaye JH; Coburn JW
    J Clin Endocrinol Metab; 1975 Aug; 41(2):339-45. PubMed ID: 169280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy.
    Gonzalez MT; Gonzalez C; Griñó JM; Castelao AM; Mariñoso ML; Serrano S; Bonnin R; Carreras L; Alsina J
    Transplant Proc; 1990 Aug; 22(4):1407-11. PubMed ID: 2389341
    [No Abstract]   [Full Text] [Related]  

  • 60. Hyperparathyroidism in the maintenance dialysis patient.
    Glassford DM; Remmers AR; Sarles HE; Lindley JD; Scurry MT; Fish JC
    Surg Gynecol Obstet; 1976 Mar; 142(3):328-32. PubMed ID: 1251311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.